secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001558370-23-007985
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRADIMED reports record Q1 revenue $15.5M; raises FY 2023 guidance
------------------------------------------------------------------

- Q1 revenue $15.5M (+25.7% YoY); GAAP diluted EPS $0.27, non-GAAP $0.30.
- Operating income $4.0M, up 30% YoY; gross margin 75.7% vs 76.2%.
- Paid special dividend of $1.05 per share during Q1.
- Q2 2023 guidance: revenue $15.6-15.8M, non-GAAP EPS $0.30-0.32.
- FY 2023 guidance raised: revenue $62-63.5M, non-GAAP EPS $1.26-1.35.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837023007985/0001558370-23-007985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837023007985/irmd-20230504x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-007985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer